Phase 1, randomized, crossover study comparing intravenous GTX-104 to oral nimodipine in healthy human subjects - Amresh Kumar; Carrie D’Andrea; Prashant Kohli; S. George Kottayil; James Longstreth; R. Loch Macdonald (PLoS ONE, 2025)